Pharmacotherapy for obesity management in adults: 2025 clinical practice guideline update
Canadian Medical Association Journal · 11.08.2025 · 197 (27) · E797-E809
DOI: 10.1503/cmaj.250502 ↗Kurz gefasst
Leitlinie in der Zeitschrift Canadian Medical Association Journal, online erschienen am 10.08.2025. Verfasst von Sue D Pedersen und 5 weiteren Autor:innen. Beteiligte Einrichtung: C-ENDO Diabetes and Endocrinology Clinic, and University of Calgary (Pedersen), Calgary, Alta.; Department of Endocrinology (Manjoo, Jain), Universit…. Hauptthemen laut MEDLINE: Obesity, Anti-Obesity Agents, Obesity Management. Die Arbeit wurde bisher 85-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- C-ENDO Diabetes and Endocrinology Clinic, and University of Calgary (Pedersen), Calgary, Alta.; Department of Endocrinology (Manjoo, Jain), University of British Columbia, Vancouver, BC; University of Victoria (Manjoo),…
Zitieren
APA
Pedersen, S. D., Manjoo, P., Dash, S., Jain, A., Pearce, N., & Poddar, M. (2025). Pharmacotherapy for obesity management in adults: 2025 clinical practice guideline update. Canadian Medical Association Journal, 197(27), E797-E809. https://doi.org/10.1503/cmaj.250502
Vancouver
Pedersen SD, Manjoo P, Dash S, Jain A, Pearce N, Poddar M. Pharmacotherapy for obesity management in adults: 2025 clinical practice guideline update. Canadian Medical Association Journal. 2025;197(27):E797-E809. doi:10.1503/cmaj.250502
BibTeX
@article{Pedersen2025,
author = {Pedersen, Sue D and Manjoo, Priya and Dash, Satya and Jain, Akshay and Pearce, Nicole and Poddar, Megha},
title = {Pharmacotherapy for obesity management in adults: 2025 clinical practice guideline update},
journal = {Canadian Medical Association Journal},
year = {2025},
volume = {197},
number = {27},
pages = {E797--E809},
doi = {10.1503/cmaj.250502}
}
EUVIMED